ConductScience.org, home

Paper29648554

Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity.

Zhou J and 7 others. Org Biomol Chem, 2018. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity. Papers, record 29648554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29648554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity.
PubMed
Journal
Org Biomol Chem
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2019-02-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou JJie
2Ji MMing
3Yao HHaiping
4Cao RRan
5Zhao HHailong
6Wang XXiaoyu
7Chen XXiaoguang
8Xu BBailing

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Breast NeoplasmsMajor topic
Poly(ADP-ribose) Polymerase InhibitorsMajor topic
QuinazolinesMajor topic
Animals
Cell Line, Tumor
Drug Design
Female
Humans
Mice
Molecular Docking Simulation
Poly (ADP-Ribose) Polymerase-1
Poly(ADP-ribose) Polymerases
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
41379296Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review.Mol Divers2026https://conductscience.org/library/papers/41379296PubMed
40999977Quinazolinone derivatives as potential anti‑tumor agents: Structural features and molecular mechanisms in inducing cell death (Review).Int J Mol Med2025https://conductscience.org/library/papers/40999977PubMed
40776679Small molecule inhibitors for treating breast cancer: drug analysis based on the pathogenesis of breast cancer.Future Med Chem2025https://conductscience.org/library/papers/40776679PubMed
40649817Quinazolinedione Derivatives as Potential Anticancer Agents Through Apoptosis Induction in MCF-7.Int J Mol Sci2025https://conductscience.org/library/papers/40649817PubMed
38874023Patents on PARP-1 Inhibitors for the Management of Cancer from 2017-2023.Recent Pat Anticancer Drug Discov2025https://conductscience.org/library/papers/38874023PubMed
35754904I2/TBHP mediated domino synthesis of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-aryl/alkyl benzamides and evaluation of their anticancer and docking studies.RSC Adv2022https://conductscience.org/library/papers/35754904PubMed
35521104Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors.RSC Adv2020https://conductscience.org/library/papers/35521104PubMed
32621411[Poly adenosine diphosphate-ribosylation and neurodegenerative diseases].Zhejiang Da Xue Xue Bao Yi Xue Ban2020https://conductscience.org/library/papers/32621411PubMed
32363314DMAP-Catalyzed One-Pot Synthesis of Quinazoline-2,4-diones from 2-Aminobenzamides and Di-tert-butyl Dicarbonate.ACS Omega2020https://conductscience.org/library/papers/32363314PubMed
31032048Deep eutectic solvent for an expeditious sono-synthesis of novel series of bis-quinazolin-4-one derivatives as potential anti-cancer agents.R Soc Open Sci2019https://conductscience.org/library/papers/31032048PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene
PARP1264761PubTator's text mininghttps://conductscience.org/library/genes/64761NCBI Gene
PARP210038PubTator's text mininghttps://conductscience.org/library/genes/10038NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29648554

GET https://conductscience.org/api/papers/v1/29648554/authors